ketoconazole has been researched along with Growth Disorders in 1 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Growth Disorders: Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dutta, D | 1 |
| Jain, R | 1 |
| Maisnam, I | 1 |
| Mishra, PK | 1 |
| Ghosh, S | 1 |
| Mukhopadhyay, S | 1 |
| Chowdhury, S | 1 |
1 other study available for ketoconazole and Growth Disorders
| Article | Year |
|---|---|
Isolated Cushing's syndrome in early infancy due to left adrenal adenoma: an unusual aetiology.
Topics: 14-alpha Demethylase Inhibitors; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Ad | 2012 |